Evexia Lifecare Limited has signed a significant agreement to acquire a 65% stake in Diponed Bio Private Limited, a leader in ...
A growing demand for textiles and smart packaging solutions will drive nanocrystalline cellulose demand.Wilmington, Delaware, ...
By engineering the surface of these materials with specific ligands, peptides, or growth factors, they can effectively modulate cellular behaviors and promote tissue-specific regeneration processes.
Pharma chemicals manufacturer Evexia Lifecare has bought majority stake in Diponed Bio. Evexia acquired 18,600 fresh equity ...
AI could have long-term climate benefits. For now, though, it is spiking carbon emissions and extending the life of fossil ...
In an exciting development within the healthcare and biotechnology sectors, Evexia Lifecare Limited (Evexia) has signed a ...
The global synthetic biology market is anticipated to reach USD 31.52 billion in 2029 from USD 12.33 billion in 2024, with a ...
Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from ...
"So thinking about a doctor that can operate some machine, and all of the signals could be transmitted to Hawaiʻi in real-time, and they can operate these teeny, tiny small-scale robots for the proper ...
A robot, trained for the first time by watching videos of seasoned surgeons, executed the same surgical procedures as ...